Back to top
more

RTI Surgical, Inc. (RTIX)

(Delayed Data from NSDQ)

$5.52 USD

5.52
292,727

+0.20 (3.76%)

Updated May 3, 2019 04:00 PM ET

After-Market: $5.50 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Surgalign Holdings, Inc. [RTIX]

Reports for Purchase

Showing records 1 - 20 ( 28 total )

Company: Surgalign Holdings, Inc.

Industry: Medical - Instruments

Record: 1

10/08/2019

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for RTIX

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Instruments

Record: 2

06/22/2016

Daily Note

Pages: 3

Termination of Coverage-Analyst(s) Departure

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: GRISEWOOD S

Price: 10.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Instruments

Record: 3

03/01/2016

Company Report

Pages: 6

RTI Surgical reported strong financial results for their most recent Q4/2015 quarter including 2016 Guidance

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Instruments

Record: 4

11/24/2015

Company Report

Pages: 6

Q4/15 Guidance muted

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Instruments

Record: 5

06/11/2015

Company Report

Pages: 6

Results for Q1/15 strong, Raising 2015

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Instruments

Record: 6

02/23/2015

Company Report

Pages: 6

Results for 2014 solid, 2015 looks strong

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Instruments

Record: 7

10/31/2014

Company Report

Pages: 6

Q3 Results strong; Estimates increased

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Instruments

Record: 8

10/16/2014

Company Report

Pages: 13

we are initiating coverage on RTIX shares with a BUY rating and 12-18 month price target of $7.30 per share.

Provider: DAWSON JAMES SECURITIES, INC.

Analyst: WASSERMAN R

Price: 50.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 9

07/02/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 10

07/02/2013

Company Report

Pages: 4

We are dropping coverage due to the realignment of the Med Tech research team.

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 11

06/13/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 12

06/13/2013

Company Report

Pages: 7

Pioneer Complements Core Revenue; Expands Distribution Reach

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 13

04/26/2013

Daily Note

Pages: 4

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 14

04/25/2013

Company Report

Pages: 7

Mixed Q - Maintain Neutral Pending Visibility from Warning Letter, Int''l

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 15

04/17/2013

Daily Note

Pages: 8

1Q13 MedTech Preview: ALGN ICUI TRIB CRY CPTS ATEC RTIX SLTM VOLC ATRC (Part 1)

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 16

04/03/2013

Industry Report

Pages: 9

Healthcare - 1Q 2013: Quarterly Medical Technology Trading & Acquisition Update

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 17

02/07/2013

Company Report

Pages: 7

Downgrading to Neutral as We Wait for Better Clarity & Growth

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 18

02/06/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 19

02/05/2013

Company Report

Pages: 4

4Q Preview: Thurs, Feb 7 Before Open - Guidance Conservative, Could Beat

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 10.00

Research Provided by a Third Party

Company: Surgalign Holdings, Inc.

Industry: Medical - Biomedical and Genetics

Record: 20

02/01/2013

Daily Note

Pages: 7

Healthcare- 4Q12 Med Tech Earnings Preview

Provider: Roth Capital Partners, Inc.

Analyst: DOLAN M

Price: 25.00

Research Provided by a Third Party
// eof